Realta Life Sciences Inc.

Realta Life Sciences Inc. focuses on acute graft-versus-host disease, a serious complication seen after allogeneic stem cell transplantation. Its clinical research is centered on hospital-based care for patients with steroid-refractory disease, with attention to immune-mediated tissue injury and post-transplant complications.

• Acute graft-versus-host disease
• Allogeneic stem cell transplantation
• Steroid-refractory disease

The sponsor’s research activity is concentrated in settings where immunological complications of transplantation require targeted therapeutic options.